VYGR ▼ -3.4% - Voyager Therapeutics, Inc.
$VYGR - Voyager’s Tau-Targeted Gene Therapy VY1706 and Anti-Tau Antibody VY7523 for Alzheimer’s Disease to Be Featured in Poster Presentations at CTAD 2026
27-OCT-2026 08:01 AM ET
Share this post
More filings for $VYGR
VYGR ▼ -1.8% - Voyager Therapeutics, Inc.Oct 21, 2026VYGR - Voyager Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026$VYGR SEC Filing Update (31-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 31, 2026
View full $VYGR filing history →💬 Comments
Loading comments…
Leave a comment
